Nuclear Medicine Software Market, By Type (Patient Data Management Software, Imaging and Visualization Software, Analysis and Quantification Software, Clinical Decision Support Software, Dosimetry Software, Workflow and Scheduling Software, Treatment Planning Software, and Others (Artificial Intelligence (AI) and Analytics Software, etc.)), By Modality (Positron Emission Tomography (PET), Single Photon Emission Computed Tomography (SPECT), Hybrid Imaging Software (PET/CT, SPECT/CT, PET/MRI), and Others (Planar Scintigraphy, hybrid systems)), By Therapeutic Area (Oncology, Cardiology, Neurology, Endocrinology, Gastroenterology, and Others (Orthopedics, Infectious disease imaging, etc.)), By Deployment Model (On-Premise and Cloud-Based), By Integration Complexity (Standalone Software and Integrated Software Solutions), By Pricing Model (Subscription-based Pricing, Perpetual License Pricing, Usage-based Pricing (pay-per-use), Freemium or Trial-based Pricing, and Customized or Enterprise Pricing), By End User (Hospitals and Clinics, Diagnostic Imaging Centers, Academic and Research Institutions, and Pharmaceutical and Biotechnology Companies), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) - Growth Trends and Forecasts (2026-2033)